CHMP endorses Eli Lilly’s GLP-1 pill and three other new drugs
Eli Lilly secured EU regulatory backing for its oral GLP-1 pill orforglipron on Friday as it looks to catch up with competitor Novo’s Wegovy pill. The European Medicines Agency’s human medicines committee (CHMP)
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.